Home Biosimilar Antibodies Microbiology SARS-CoV antibody Lenzilumab (Anti-CSF2 / GM-CSF) For research use only.
Not for use in humans.

Lenzilumab (Anti-CSF2 / GM-CSF)

Synonyms: KB 003

Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.

Lenzilumab (Anti-CSF2 / GM-CSF)

Purity & Quality Control

≥99

Choose Selective SARS-CoV Inhibitors

Biological Activity

Description Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.

Product Details

CAS No. 1229575-09-0
Molecular Weight 145.72
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lenzilumab (Anti-CSF2 / GM-CSF) | Lenzilumab (Anti-CSF2 / GM-CSF) supplier | purchase Lenzilumab (Anti-CSF2 / GM-CSF) | Lenzilumab (Anti-CSF2 / GM-CSF) cost | Lenzilumab (Anti-CSF2 / GM-CSF) manufacturer | order Lenzilumab (Anti-CSF2 / GM-CSF) | Lenzilumab (Anti-CSF2 / GM-CSF) distributor